Tag: Cancer: Lymphoma
Calquence Approved for Mantle Cell Lymphoma
For patients who have not responded to at least one prior treatment or who have relapsed
Gene Expression Assay Classifies Diffuse Large B-Cell Lymphoma
Assay assesses expression of 21 markers, classifies most samples into expected subtype
Gene Tx Approved for Certain Types of B-Cell Lymphoma
First such treatment for certain types of non-Hodgkin lymphoma
PFS Up With Obinutuzumab-Based Tx in Follicular Lymphoma
Induction, maintenance treatment with obinutuzumab-based chemo beats rituximab
FDA Approves Aliqopa for Follicular Lymphoma
Aliqopa, a kinase inhibitor, blocks several enzymes that promote cell growth
Immune Status Tied to Outcomes in Third-Gen CAR T-Cell Therapy
In leukemia/lymphoma, after treatment CD19-targeting chimeric antigen receptor T-cell therapy
Nephrotic Syndrome Reported With Everolimus, Voriconazole
Case report of patient with relapsed Hodgkin's lymphoma treated with everolimus for five years
Health Care Use Up for Relapse-Free Hodgkin’s Survivors
Rate of outpatient visits, inpatient bed-days up, especially for those requiring multiple chemo courses
HBV, HCV Coinfection Ups Non-Hodgkin Risk in ART-Treated HIV
Increased risk for NHL for HIV-infected patients receiving ART with chronic coinfection with HBV, HCV
Social Reintegration of Hodgkin’s Survivors Impeded by Fatigue
Significant negative association of severe fatigue and employment among male and female survivors
